BCC4: Clive Woolfe on Chronic Liver Disease
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share

BCC4: Clive Woolfe on Chronic Liver Disease

  • 720 views
Uploaded on

Clive Woolfe, Irishman and RPA Intensivist, speaks at Bedside Critical Care Conference. In this podcast, he gives an overview of the prognostication and management of chronic liver disease. See......

Clive Woolfe, Irishman and RPA Intensivist, speaks at Bedside Critical Care Conference. In this podcast, he gives an overview of the prognostication and management of chronic liver disease. See www.intensivecarenetwork.com for the podcast.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
720
On Slideshare
322
From Embeds
398
Number of Embeds
4

Actions

Shares
Downloads
10
Comments
0
Likes
0

Embeds 398

http://www.intensivecarenetwork.com 197
http://intensivecarenetwork.com 188
http://www.slideee.com 9
http://icn.wpengine.com 4

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Chronic Liver Disease BCC, Cairns, September 2013 Clive Woolfe
  • 2. Definitions Organ
  • 3.   Support Prognositicating... Facts
  • 4.   and
  • 5.   Figures
  • 6. Cirrhosis “late stage of progressive hepatic fibrosis” Death from Portal Hypertension, progressive MOF, not encephalopathy
  • 7. The economic cost and health burden of liver disease in Australia January 2013
  • 8. Child-Turcotte-Pugh Abdominal Surgery Mortality (%) ! 10 ! 30 ! 82
  • 9. MELD Model for Endstage Liver Disease 9.57 x ln(Creatinine) + 3.78 x ln(Bilirubin) +11.2 x In(INR) + 6.43
  • 10. MELD Model for Endstage Liver Disease 9.57 x ln(Creatinine) + 3.78 x ln(Bilirubin) +11.2 x In(INR) + 6.43 20 40 60 80 100 0 10 15 20 25 30 40 83 80 78 74 71 90 81 63 42 21 Waiting List Survival 1 year post OLTx Survival MELD Score %
  • 11. Terminal Disease... progressive MOF
  • 12. ICU
  • 13. ICU Reversible precipitant? ! Organ support as a bridge to transplant
  • 14. Precipitants Look for Reversibility Drugs BDZ Narcotics Ammonia Diet Infection GI bleeding Hypokalaemia Constipation Metab Alkalosis Vascular Occlusion Porto-systemic shunts NH3 Dehydration V&D Hemorrhage Diuretics Paracentesis HCC Alcohol
  • 15. Variceal Haemorrhage Median Follow Up 2.5 years
  • 16. No survival advantage 2x Encephalopathy ?
  • 17. Organ support
  • 18. Neurological NH3 Serial Examination Hippus Clonus Hyperreflexia
  • 19. Efficacy of “Treatments” for HE +
  • 20. Respiratory Bleeding Sepsis ?Hepato-pulmonary Syndrome Porto-Pulmonary Hypertension PAP Massive TidalVolumes Paracentesi
  • 21. CVS E. Coli
  • 22. Renal/Fluids Renal hypoperfusion RAA activation Low Intravascular Volume vs. High TBW Hepatic CongestionHepatorenal Syndrome Late presentation: Low muscle mass Low urea production “Euvolaemia”
  • 23. Gastrointestinal
  • 24. Precipitating Event SBP Prophylaxis Sepsis ! 24% of cirrhotic inpatients RTI > UTI > C.Diff Mortality increase: 39 to 49%
  • 25. Finally... ICU Reversible precipitant? ! Organ support as a bridge to transplant
  • 26. ICU Reversible precipitant? ! Organ support as a bridge to transplant